MYBL2 and renal carcinoma: When focus on both open and actively expressed genes, HBG2, MYBL2, and TPSAB1. The former is hemoglobin gene, though it is not prognostic in renal cancer, the 5-year survival of low expression of HBG2 is significantly higher than highly expressed ones.